Sulfur Amino Acids, Energy Metabolism and Obesity
STAY
Dietary Sulfur Amino Acid Restriction, Energy Metabolism and Obesity
1 other identifier
interventional
61
1 country
1
Brief Summary
The primary objective of the trial is to establish the effects of dietary sulfur amino acid (SAA) restriction on body weight, body composition and energy expenditure in humans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2021
CompletedFirst Posted
Study publicly available on registry
January 8, 2021
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 17, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 17, 2022
CompletedMay 19, 2022
May 1, 2022
1 year
January 5, 2021
May 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in body weight
Kilograms
At baseline, 4 and 8 weeks
Secondary Outcomes (15)
Changes in resting energy expenditure
At baseline, 4 and 8 weeks
Changes in substrate oxidation
At baseline, 4 and 8 weeks
Changes in body composition
At baseline, 4 and 8 weeks
Changes in plasma concentrations of SAA and related intermediates and compounds
At baseline, 4 and 8 weeks
Changes in urine concentrations of SAA and related intermediates and compounds
At baseline, 4 and 8 weeks
- +10 more secondary outcomes
Study Arms (2)
Low SAA diet
EXPERIMENTALDietary intervention
High SAA diet
ACTIVE COMPARATORDietary intervention
Interventions
Eligibility Criteria
You may qualify if:
- Healthy participants with overweight and obesity (BMI 27-35 kg/m2)
- Waist circumference \> 80 cm for women and \> 94 cm for men
You may not qualify if:
- Smoking
- Presence of chronic disease
- Established co-morbidities
- Already on a vegan diet or have been the last month
- Pregnancy
- Breastfeeding the last 3 months
- Unstable body weight the last 3 months
- High intensity training \> 3 times weekly
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oslolead
- Charles University, Czech Republiccollaborator
- Maastricht Universitycollaborator
- University of Oxfordcollaborator
Study Sites (1)
Centre for Clinical Nutrition, University of Oslo/Oslo University Hospital
Oslo, 0372, Norway
Related Publications (3)
Olsen T, Vinknes KJ, Barvikova K, Stolt E, Lee-Odegard S, Troensegaard H, Johannessen H, Elshorbagy A, Sokolova J, Krijt J, Krizkova M, Ditroi T, Nagy P, Ovrebo B, Refsum H, Thoresen M, Retterstol K, Kozich V. Dietary sulfur amino acid restriction in humans with overweight and obesity: Evidence of an altered plasma and urine sulfurome, and a novel metabolic signature that correlates with loss of fat mass and adipose tissue gene expression. Redox Biol. 2024 Jul;73:103192. doi: 10.1016/j.redox.2024.103192. Epub 2024 May 17.
PMID: 38776754DERIVEDOlsen T, Stolt E, Ovrebo B, Elshorbagy A, Tore EC, Lee-Odegard S, Troensegaard H, Johannessen H, Doeland B, Vo AAD, Dahl AF, Svendsen K, Thoresen M, Refsum H, Rising R, Barvikova K, van Greevenbroek M, Kozich V, Retterstol K, Vinknes KJ. Dietary sulfur amino acid restriction in humans with overweight and obesity: a translational randomized controlled trial. J Transl Med. 2024 Jan 9;22(1):40. doi: 10.1186/s12967-023-04833-w.
PMID: 38195568DERIVEDStolt E, Olsen T, Elshorbagy A, Kozich V, van Greevenbroek M, Ovrebo B, Thoresen M, Refsum H, Retterstol K, Vinknes KJ. Sulfur amino acid restriction, energy metabolism and obesity: a study protocol of an 8-week randomized controlled dietary intervention with whole foods and amino acid supplements. J Transl Med. 2021 Apr 15;19(1):153. doi: 10.1186/s12967-021-02824-3.
PMID: 33858441DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kjetil Dr Retterstøl, Prof. dr med
University of Oslo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
January 5, 2021
First Posted
January 8, 2021
Study Start
March 1, 2021
Primary Completion
March 17, 2022
Study Completion
March 17, 2022
Last Updated
May 19, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share
EU privacy regulations do not permit public sharing of IPD as long as the project is ongoing. Anonymized data can be shared after the project and biobank permissions end in 2030. The study protocol will be published.